BIRMINGHAM, Ala. – Cory Watson Attorneys is pleased to announce that firm Shareholder and Principal attorney Douglas Dellaccio is recognized as one of Birmingham Magazine’s “Top Attorneys 2019.”
Birmingham Magazine published the list in its March 2019 issue. Recognized attorneys were selected via a peer survey of more than 4,000 local lawyers and Birmingham Bar Association members. Attorneys were recognized for their experience and knowledge within 35 practice areas. Birmingham Magazine staff members reviewed the results to vet both voters and winners.
About Shareholder Douglas Dellaccio
For over 20 years, Douglas Dellaccio has served clients by leveling the playing field against insurance companies and major corporations. His practice at Cory Watson Attorneys focuses on civil litigation, personal injury, defective medical devices, products liability, and antitrust litigation.
As an Alabama native, his roots run deep in the Birmingham community. Doug has served the state through the Board of Directors for the Alabama Civil Justice Foundation and currently serves on the Board of Directors for the Alabama Association for Justice.
He is nationally recognized by publications such as Super Lawyers, Best Lawyers in America, and B-Metro Magazine for his leadership and outstanding work on the Cory Watson litigation team.
On behalf of Cory Watson Attorneys and our thousands of clients nationwide, we thank Douglas Dellaccio for his dedication to our firm, clients, profession, and his community.
About Cory Watson Attorneys
Cory Watson Attorneys is a nationally recognized personal injury law firm based in Birmingham, Ala., with more than 3 Billion in recoveries for clients. Attorneys are frequently at the forefront of major class actions and multidistrict litigations involving dangerous pharmaceuticals and product liability, and are often appointed to leadership positions in national cases. Firm practice areas include Personal Injury, Product Liability, Class Action, Asbestos, Business & Commercial Litigation, Dangerous Pharmaceuticals, Defective Medical Devices, and Environmental/Toxic Torts.